Literature DB >> 8697346

Bone mineral density of the spine using dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus.

D J Kwon1, J H Kim, K W Chung, J H Kim, J W Lee, S P Kim, H Y Lee.   

Abstract

To evaluate the influence of non-insulin-dependent diabetes mellitus (NIDDM) on bone mineral density (BMD), we measured BMD in 185 female patients with NIDDM using dual energy X-ray absorptiometry (DEXA). BMD was measured in lumbar vertebrae (L2-4). BMD is slightly higher in the diabetic patients compared with control subjects and bone loss related to menopause starts before the onset of menopause. The BMD of postmenopausal women showed a definite decrease with aging and there was abrupt bone loss after 55 years of age (p < 0.05). In relation to the duration of diabetes, the decrease of BMD for 15 years was 10.0%. BMD was negatively correlated with age, years since menopause (YSM), and disease duration (r = -0.584, r = -0.470, r = -0.186). These results suggest that age, YSM, and the duration of disease appear to be the risk factors for decreased BMD in the diabetic patients.

Entities:  

Mesh:

Year:  1996        PMID: 8697346     DOI: 10.1111/j.1447-0756.1996.tb00959.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  13 in total

1.  Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies.

Authors:  Lili Ma; Ling Oei; Lindi Jiang; Karol Estrada; Huiyong Chen; Zhen Wang; Qiang Yu; Maria Carola Zillikens; Xin Gao; Fernando Rivadeneira
Journal:  Eur J Epidemiol       Date:  2012-03-27       Impact factor: 8.082

Review 2.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

3.  Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice.

Authors:  Kimberly A Kyle; Thomas L Willett; Laurie L Baggio; Daniel J Drucker; Marc D Grynpas
Journal:  Endocrinology       Date:  2010-12-22       Impact factor: 4.736

4.  Menopausal bone changes and incident fractures in diabetic women: a cohort study.

Authors:  N Khalil; K Sutton-Tyrrell; E S Strotmeyer; G A Greendale; M Vuga; F Selzer; C J Crandall; J A Cauley
Journal:  Osteoporos Int       Date:  2010-07-24       Impact factor: 4.507

5.  Fracture incidence and risk of osteoporosis in female type 2 diabetic patients in Korea.

Authors:  Jong Kwan Jung; Hyo Jeong Kim; Hong Kyu Lee; Sang Soo Kim; Chan Soo Shin; Jin Taek Kim
Journal:  Diabetes Metab J       Date:  2012-04-17       Impact factor: 5.376

6.  Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus.

Authors:  P F Shan; X P Wu; H Zhang; X Z Cao; L Q Yuan; E Y Liao
Journal:  J Endocrinol Invest       Date:  2010-08-31       Impact factor: 4.256

7.  The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians.

Authors:  K C Chiu; L M Chuang; C Yoon
Journal:  BMC Med Genet       Date:  2001-02-15       Impact factor: 2.103

8.  Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?

Authors:  Shaymaa Abdalwahed Abdulameer; Syed Azhar Syed Sulaiman; Mohamed Azmi Ahmad Hassali; Karuppiah Subramaniam; Mohanad Naji Sahib
Journal:  Patient Prefer Adherence       Date:  2012-06-11       Impact factor: 2.711

9.  The Prevalence of Osteopenia and Osteoporosis Among Malaysian Type 2 Diabetic Patients Using Quantitative Ultrasound Densitometer.

Authors:  Shaymaa Abdalwahed Abdulameer; Mohanad Naji Sahib; Syed Azhar Syed Sulaiman
Journal:  Open Rheumatol J       Date:  2018-04-25

10.  Effect of vitamin D therapy on bone mineral density in patients with diabetic nephropathy; a randomized, double-blind placebo controlled clinical trial.

Authors:  Gayani Liyanage; Sarath Lekamwasam; Thilak Weerarathna; Chandrani Liyanage
Journal:  J Diabetes Metab Disord       Date:  2021-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.